Indefinite Delivery Contract SPE2D223D0002

Award Date 10/6/22
Last Date to Order 10/5/27
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV SPE2D221D0130 is a single-award indefinite delivery contract awarded to Radha Pharmaceuticals Inc., a minority-owned small disadvantaged business. The $15.9 million contract has a period of performance through June 20, 2026 and was issued by the Defense Logistics Agency Troop Support Medical, a component of the Department of Defense. The contract aims to establish a national supply source for several high-volume pharmaceutical products including gabapentin,...
This indefinite delivery contract (IDC) was awarded by the National Acquisition Center, a civilian agency of the U.S. government, to Radha Pharmaceuticals Inc., a minority-owned small disadvantaged business. The contract, valued at up to $15,026,406.75, provides for the delivery of Bupropion SA 12HR tablets in various bottle sizes and quantities to the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service over a base year period from May 16, 2021...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) valued at up to $499,999,999, awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, under the SPE2DB program, aims to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to fulfill the recurring...
The federal contract IDV award described is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The contract, valued at up to $499,999,999, runs through December 31, 2025 and allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health...
The U.S. Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to Radha Pharmaceuticals Inc., a minority-owned small disadvantaged business, for the provision of gabapentin tablets. The $23.5 million IDC has a base year and four one-year option periods, with an ultimate completion date of December 31, 2025. The contract aims to establish a reliable source of supply for high-volume gabapentin tablets in various strengths and...
The federal contract IDV award is for an Indefinite Delivery Contract (IDC) with a ceiling value of $499,999,999 issued by the Defense Logistics Agency (DLA) to the prime contractor DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The IDC, awarded under the SPE2DB program, covers a broad range of pharmaceutical products and medical supplies to fulfill the recurring medical needs of military health facilities worldwide. This includes a...
The federal contract IDV award is a single-award indefinite delivery contract (IDC) issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued up to $499,999,999, runs through November 30, 2026 and allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products to support the recurring medical supply needs of military...
The federal contract IDV award is a single-award indefinite delivery contract (IDC) between the Defense Logistics Agency (DLA) and DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $499,999,999 IDC, awarded on June 6, 2024, provides the DLA with a vehicle to issue firm fixed-price delivery orders for a wide range of pharmaceutical products to meet the recurring medical supply needs of military health facilities worldwide. The contract, under the SPE2DB...
The federal contract IDV award, valued at up to $499,999,999, is a single-award Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The contract was awarded by the Defense Logistics Agency (DLA) under the SPE2DB program, and it runs through December 31, 2025. Under this IDC, DMS Pharmaceutical Group provides a comprehensive range of pharmaceutical products and medical supplies to fulfill the recurring...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) valued up to $499,999,999 issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, under the SPE2DB program, covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities worldwide. The IDC allows the DLA to issue firm...

The federal contract IDV award SPE2D223D0002 is a single-award Indefinite Delivery Contract (IDC) to Radha Pharmaceuticals Inc., a minority-owned small disadvantaged business, for the manufacture and distribution of branded and generic pharmaceutical products. The $23.3 million IDC was awarded on October 6, 2022 by the Defense Logistics Agency (DLA) Troop Support Medical, with an ultimate completion date of October 5, 2027.

The IDC utilizes firm-fixed pricing and provides an uninterrupted supply of high-volume pharmaceutical products such as gabapentin, atorvastatin calcium, clopidogrel bisulfate, fluoxetine hydrochloride, bupropion HCL ER, naproxen, hydralazine, and celecoxib tablets and capsules to government customers including the Department of Defense, Department of Veterans Affairs, Bureau of Prisons, and Indian Health Service. The contract aims to leverage the DLA and VA Pharmaceutical Prime Vendor programs for efficient distribution of these products to government medical facilities. The original solicitation was a pre-solicitation for a national requirements contract for Bupropion HCL ER Tablets, posted on March 11, 2021, with an estimated annual usage of over 200,000 units across the various strengths and bottle configurations.

Generated 12/13/24, 9:08 AM